You are here: Industry Insights > NDMA

News List

Statement from the FDA on NDMA found in drugs outside the US europeanpharmaceuticalreview
December 10, 2019
The FDA has released a statement on the investigations into the presence of nitrosamines in some drugs; highlighting that there are currently no recalls of metformin within the US.
Sandoz voluntarily recalls ranitidine over NDMA contamination concerns europeanpharmaceuticalreview
September 27, 2019
The probable carcinogen N-nitrosodimethylamine was detected in Sandoz’s ranitidine capsules, prompting the voluntary move.
Maker Halts Distribution of Generic Zantac Due to Possible Carcinogen drugs
September 20, 2019
Novartis, the maker of a generic form of Zantac, said Wednesday it will stop selling the medicine after investigations suggested that generic and branded versions contain a known carcinogen.
NDMA discovered in samples of ranitidine medicines europeanpharmaceuticalreview
September 17, 2019
The EMA and the FDA are investigating some ranitidine medicines after they were found to contain NDMA, a probable human carcinogen.
Zantac May Contain Small Amounts of Known Carcinogen drugs
September 16, 2019
A substance that could cause cancer has been found in some ranitidine heartburn and ulcer medicines, including the brand-name drug Zantac...

Previous page 1 2 3 4 Next page